RE: Information

lambwell

New member
RE: Information

Hi to all,
Lundbeck, which faces the expiry of patents on its cash cow antidepressant Cipralex/Lexapro in major markets as of 2012, said Ovation's pipeline was expected to drive growth significantly in the coming years through multiple new product launches. Lundbeck has repeatedly signalled its intention to buy a drug or an entire company to replace revenue likely to decrease when the Lexapro patents expire.
 
Back
Top